Skip to content

Amgen AMGN Total Current Assets

Total Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$54.84B+32.9%
Pfizer logo
PfizerPFE
$42.82B-6.6%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$18.45B+9.4%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$589.04M+156%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$395.25M+12.3%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$234.03M+59.7%

Other financials

Income statement

See full
Revenue$8.6B+5.8%
Gross profit$5.9B+13.4%
Operating income$2.7B+126%
Net income$1.8B+5.1%
EPS (diluted)$3.34+4.4%

Balance sheet

See full
Cash & equivalents$559.0M+10.0%
Total debt$57.3B-0.1%
Total equity$9.2B+48.1%
Total assets$92.5B+3.5%

Cash flow

See full
Operating cash flow$2.2B+57.4%
CapEx$712.0M+73.2%
Free cash flow$1.5B+50.7%

Valuation

See full
Market cap$212.16B+30.0%
Enterprise value$268.92B+22.9%
P/E27.2×+2.5×
P/S5.7×+1.0×

Profitability

See full
Gross margin68.3%+5.3pp
Operating margin28.4%+6.6pp
Net margin21%+3.6pp
FCF margin23.1%-8.9pp

Returns & leverage

See full
Return on equity101.3%-4.4pp
Debt / equity6.2×-3.0×
Current ratio1.3×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amgen's total current assets?
Amgen (AMGN) reported total current assets of $31.48B in Q1 2026.
How has Amgen's total current assets changed year-over-year?
Amgen's total current assets increased by 16.9% year-over-year, from $26.93B to $31.48B.
What is the long-term trend for Amgen's total current assets?
Over 5 years (2020 to 2025), Amgen's total current assets has grown at a 6.6% compound annual growth rate (CAGR), from $21.14B to $29.06B.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.